Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Adverse event reporting in publications compared with sponsor database for cancer clinical trials.

Scharf O, Colevas AD.

J Clin Oncol. 2006 Aug 20;24(24):3933-8.

PMID:
16921045
2.

Reporting of adverse events in randomized controlled trials of highly active antiretroviral therapy: systematic review.

Chowers MY, Gottesman BS, Leibovici L, Pielmeier U, Andreassen S, Paul M.

J Antimicrob Chemother. 2009 Aug;64(2):239-50. doi: 10.1093/jac/dkp191. Epub 2009 May 28. Review.

PMID:
19477890
3.

Topical bovine thrombin: a 21-year review of topical bovine thrombin spontaneous case safety reports submitted to FDA's Adverse Event Reporting System.

Clark JA, Humphries JE, Crean S, Reynolds MW.

Pharmacoepidemiol Drug Saf. 2010 Feb;19(2):107-14. doi: 10.1002/pds.1874. Review.

PMID:
20014051
4.

Safety of doxycycline and minocycline: a systematic review.

Smith K, Leyden JJ.

Clin Ther. 2005 Sep;27(9):1329-42. Review.

PMID:
16291409
5.
6.
7.

Adherence to CONSORT adverse event reporting guidelines in randomized clinical trials evaluating systemic cancer therapy: a systematic review.

PĂ©ron J, Maillet D, Gan HK, Chen EX, You B.

J Clin Oncol. 2013 Nov 1;31(31):3957-63. doi: 10.1200/JCO.2013.49.3981. Epub 2013 Sep 23. Review.

PMID:
24062406
8.

Supporting quality and patient safety in cancer clinical trials.

Badalucco S, Reed KK.

Clin J Oncol Nurs. 2011 Jun;15(3):263-5. doi: 10.1188/11.CJON.263-265. Review.

PMID:
21624861
9.

Reporting of vaccine safety data in publications: systematic review.

Bonhoeffer J, Zumbrunn B, Heininger U.

Pharmacoepidemiol Drug Saf. 2005 Feb;14(2):101-6. Review.

PMID:
15386705
10.

Spontaneous adverse event signaling methods: classification and use with health care treatment products.

Clark JA, Klincewicz SL, Stang PE.

Epidemiol Rev. 2001;23(2):191-210. Review.

PMID:
12192733
11.

Review of safety assessment methods used in pediatric psychopharmacology.

Greenhill LL, Vitiello B, Riddle MA, Fisher P, Shockey E, March JS, Levine J, Fried J, Abikoff H, Zito JM, McCracken JT, Findling RL, Robinson J, Cooper TB, Davies M, Varipatis E, Labellarte MJ, Scahill L, Walkup JT, Capasso L, Rosengarten J.

J Am Acad Child Adolesc Psychiatry. 2003 Jun;42(6):627-33. Review.

PMID:
12921469
12.

Patient-reported outcomes and the evolution of adverse event reporting in oncology.

Trotti A, Colevas AD, Setser A, Basch E.

J Clin Oncol. 2007 Nov 10;25(32):5121-7. Review.

PMID:
17991931
13.

Safety of gadobenate dimeglumine (MultiHance): Summary of findings from clinical studies and postmarketing surveillance.

Shellock FG, Parker JR, Venetianer C, Pirovano G, Spinazzi A.

Invest Radiol. 2006 Jun;41(6):500-9. Review.

PMID:
16763468
14.

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment.

Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, Langer C, Murphy B, Cumberlin R, Coleman CN, Rubin P.

Semin Radiat Oncol. 2003 Jul;13(3):176-81. Review.

PMID:
12903007
15.

Incidence and US costs of corticosteroid-associated adverse events: a systematic literature review.

Sarnes E, Crofford L, Watson M, Dennis G, Kan H, Bass D.

Clin Ther. 2011 Oct;33(10):1413-32. doi: 10.1016/j.clinthera.2011.09.009. Epub 2011 Oct 13. Review.

PMID:
21999885
16.

Topical bovine thrombin and adverse events: a review of the literature.

Clark J, Crean S, Reynolds MW.

Curr Med Res Opin. 2008 Jul;24(7):2071-87. doi: 10.1185/03007990802186417 . Epub 2008 Jun 11. Review.

PMID:
18549663
17.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
18.

Original research: Intravenous ribavirin--review of the FDA's Emergency Investigational New Drug Database (1997-2008) and literature review.

Riner A, Chan-Tack KM, Murray JS.

Postgrad Med. 2009 May;121(3):139-46. doi: 10.3810/pgm.2009.05.2014. Review.

PMID:
19491552
19.

Publication bias in the medical literature: a review by a Canadian Research Ethics Board.

Hall R, de Antueno C, Webber A; Canadian Research Ethics Board..

Can J Anaesth. 2007 May;54(5):380-8. Review.

PMID:
17470890
20.

Safety and clinical effectiveness of midazolam versus propofol for procedural sedation in the emergency department: a systematic review.

Hohl CM, Sadatsafavi M, Nosyk B, Anis AH.

Acad Emerg Med. 2008 Jan;15(1):1-8. doi: 10.1111/j.1553-2712.2007.00022.x. Review.

Supplemental Content

Support Center